BARCELONA, SPAIN / August 11, 2025 / Longevity is experiencing a scientific revolution, yet most consumer products lag behind. While wearables and wellness hacks offer health insights, few rely on validated cellular science - until now. Omniscope, a pioneering TechBio company co-founded by Prof. Holger Heyn, Vijay Vaswani, and Lynnette Ang, is transforming the field with osLongevity, a platform that tracks and optimizes aging through immune system analysis at the cellular level.

With years of expertise in immune profiling and AI-driven analytics - applied to cancer, autoimmunity, vaccines, and transplants - Omniscope recently showcased a GenAI breakthrough, engineering immune cells for scalable, affordable therapies and launched its pioneering osLongevity product. osLongevity redefines healthspan, focusing on years of full physical and cognitive vitality by modeling aging cell by cell. Unlike fragmented data from other tech (e.g., heart rate), it offers a comprehensive aging profile, easily queried like ChatGPT.

Read further on Business Insider.